A New Retrospective Study Shows PuraBond Benefits in Adult Tonsillectomy

Tonsillectomy is one of the most common surgical procedures and accounts for 17% of elective...

Corporate and “Meet the experts” events: The winning strategy of 3-D Matrix

3-D Matrix continues to be focused on its events strategy with the aim of continuing to develop its...

First clinical study evaluating the use of PuraBond for the reduction of post-op haemorrhage and post-op complications in Transoral Robotic Surgery (TORS)

The use of Transoral Robotic surgery (TORS) is increasingly growing in Head and Neck and in Ear,...

A new multicentre study investigating PuraStat efficacy, safety, and ease of use for haemostasis in endonasal surgery (turbinate reduction, septoplasty and FESS).

Bleeding is a common intraoperative and/or post-operative issue in Endoscopic Endonasal Surgery...

3-D Matrix keeps aiming in the ENT and Plastic Surgery medical areas with PuraBond

The 3-D Matrix agenda keeps being filled with a selection of events, including those dedicated to...

3-D Matrix ranked in the Top 500 Fastest Growing Companies in Asia-Pacific region published by Financial Times

We are pleased to share that 3-D Matrix has been ranked 179th on the list of the 500...